Onyx liquid embolic for active bleeding outside the brain and heart
Part of Digestive system, Injuries & trauma clinical trials.
This trial tests a liquid material called Onyx that is injected into blood vessels to stop active bleeding in areas like the arms, legs, belly, or chest. It may help people with uncontrolled bleeding that needs to be blocked quickly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 22 years or older.
- You have active bleeding in a blood vessel outside the brain and heart, confirmed by scans or cameras.
- You or your legal representative can sign a consent form.
- Your doctor believes you will live longer than 30 days.
- The bleeding spot has not been treated with an embolization before.
- You are not pregnant or breastfeeding.
- You do not have an active infection or allergies to the Onyx liquid or imaging dyes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medical glue, called Histoacryl, to stop active bleeding in blood vessels in the belly or chest. It might be an option for people who need a minimally invasive way to stop bleeding when other treatments haven't worked.
This trial tests a new coil system that blocks abnormal connections between arteries and veins (called arteriovenous malformations or fistulas). The coils are placed through a small tube in the blood vessel to stop blood from flowing the wrong way, which may help reduce symptoms and improve blood flow.
This is a registry—a database that tracks patient outcomes—for people receiving Okami Medical devices. By joining, you help doctors understand how well these devices work and whether they're safe over time.
This trial tests a drug called VMX-C001 to quickly reverse the effects of certain blood thinners (Factor Xa inhibitors) in people who need urgent surgery with a high risk of bleeding. It compares VMX-C001 to standard care to see which is more effective at helping blood clot normally.
This trial tests a new liquid material (called a liquid embolic system) that is injected into the abnormal blood vessels in the brain to block them off. It is for people who have a cerebrovascular malformation and can be treated with a catheter from inside the blood vessel.
This trial studies whether a newer “OTSC” procedure works as well as a standard procedure called angiographic embolization to stop active, hard-to-control upper gastrointestinal bleeding. It may help people whose bleeding continues or comes back even after initial endoscopy treatment.
Hear when a new Trauma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.